Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
EPRX
GLSI
Add up to 3 more stocks
EPRX
Eupraxia Pharmaceuticals Inc.
-0.06%
$7.74-0.00Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$259.14M
52W Range
$5.25 - $9.32
GLSI
Greenwich LifeSciences, Inc.
-6.62%
$15.79-1.12Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$231.77M
52W Range
$7.78 - $34.10
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.55 | 74.36 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -38.3% | -695.6% |
| ROA | -36.0% | -244.3% |
| ROIC | -43.6% | -701.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 16.00 | 1.54 |
| Quick Ratio | 16.00 | 1.54 |
| Debt/Equity | 0.01 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.